Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Feb 3:11:1112270.
doi: 10.3389/fcell.2023.1112270. eCollection 2023.

Cost-effective sequence analysis of 113 genes in 1,192 probands with retinitis pigmentosa and Leber congenital amaurosis

Affiliations

Cost-effective sequence analysis of 113 genes in 1,192 probands with retinitis pigmentosa and Leber congenital amaurosis

Daan M Panneman et al. Front Cell Dev Biol. .

Abstract

Introduction: Retinitis pigmentosa (RP) and Leber congenital amaurosis (LCA) are two groups of inherited retinal diseases (IRDs) where the rod photoreceptors degenerate followed by the cone photoreceptors of the retina. A genetic diagnosis for IRDs is challenging since >280 genes are associated with these conditions. While whole exome sequencing (WES) is commonly used by diagnostic facilities, the costs and required infrastructure prevent its global applicability. Previous studies have shown the cost-effectiveness of sequence analysis using single molecule Molecular Inversion Probes (smMIPs) in a cohort of patients diagnosed with Stargardt disease and other maculopathies. Methods: Here, we introduce a smMIPs panel that targets the exons and splice sites of all currently known genes associated with RP and LCA, the entire RPE65 gene, known causative deep-intronic variants leading to pseudo-exons, and part of the RP17 region associated with autosomal dominant RP, by using a total of 16,812 smMIPs. The RP-LCA smMIPs panel was used to screen 1,192 probands from an international cohort of predominantly RP and LCA cases. Results and discussion: After genetic analysis, a diagnostic yield of 56% was obtained which is on par with results from WES analysis. The effectiveness and the reduced costs compared to WES renders the RP-LCA smMIPs panel a competitive approach to provide IRD patients with a genetic diagnosis, especially in countries with restricted access to genetic testing.

Keywords: cost-effective; high-throughput; inherited retinal diseases; smMIPs; targeted gene sequencing.

PubMed Disclaimer

Conflict of interest statement

PS is an employee of Molecular Loop Biosciences Inc. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

FIGURE 1
FIGURE 1
Average read coverage per smMIP in the RP-LCA panel.
FIGURE 2
FIGURE 2
Average coverage per nucleotide. The average number of reads per nucleotide for each individual gene are indicated by the black horizontal line within the box, the range is indicated by the whiskers. The horizontal dashed line depicts the average overall coverage (374x).
FIGURE 3
FIGURE 3
Number of solved cases per individual gene. For all genes, the inheritance mode is depicted in either black (autosomal recessive), white (autosomal dominant), or dashed (X-linked inheritance).
FIGURE 4
FIGURE 4
Minigene analysis of the splicing effect of RPE65:c.675C>A. (A) A minigene construct containing either wild-type sequence or the mutant c.675C>A variant in exon 7 was generated spanning exons 6-10 of RPE65 and was flanked by exons 3 and 5 of the RHO gene in the pCI-NEO-RHO vectors (B) After gel electrophoresis of the RT-PCR product, we observed two fragments in the wild-type situation. One fragment of 907 nt and one fragment of 825 nt corresponding to the skipping of the 82 nt exon 7. For 675C>A, we exclusively observed the 825 nt fragment, suggesting complete skipping of exon 7.

References

    1. Abu-Safieh L., Alrashed M., Anazi S., Alkuraya H., Khan A. O., Al-Owain M., et al. (2013). Autozygome-guided exome sequencing in retinal dystrophy patients reveals pathogenetic mutations and novel candidate disease genes. Genome Res. 23 (2), 236–247. 10.1101/gr.144105.112 - DOI - PMC - PubMed
    1. Al-Khuzaei S., Broadgate S., Foster C. R., Shah M., Yu J., Downes S. M., et al. (2021). An overview of the genetics of ABCA4 retinopathies, an evolving story. Genes 12 (8), 1241. 10.3390/genes12081241 - DOI - PMC - PubMed
    1. Black G. C., Sergouniotis P., Sodi A., Leroy B. P., Van Cauwenbergh C., Liskova P., et al. (2021). The need for widely available genomic testing in rare eye diseases: An ERN-EYE position statement. Orphanet J. Rare Dis. 16 (1), 142. 10.1186/s13023-021-01756-x - DOI - PMC - PubMed
    1. Cartegni L., Wang J., Zhu Z., Zhang M. Q., Krainer A. R. (2003). ESEfinder: A web resource to identify exonic splicing enhancers. Nucleic Acids Res. 31 (13), 3568–3571. 10.1093/nar/gkg616 - DOI - PMC - PubMed
    1. Cornelis S. S., Runhart E. H., Bauwens M., Corradi Z., De Baere E., Roosing S., et al. (2022). Personalized genetic counseling for Stargardt disease: Offspring risk estimates based on variant severity. Am. J. Hum. Genet. 109 (3), 498–507. 10.1016/j.ajhg.2022.01.008 - DOI - PMC - PubMed